Ameloblastoma: Clinical Trials

1 trial for Ameloblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Ameloblastoma: new trials by email Literature Review of Ameloblastoma trials Research Report on Ameloblastoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
Dabrafenib, Trametinib - Ameloblastoma, BRAF Gene Mutation
Phase 2CompletedStanford University12017-07-172024-01-30

Narrower conditions

Adamantinoma (1)

Broader conditions

Bone Diseases (1)  ·  Bone Neoplasms (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Odontogenic Tumors (1)

Interventions

dabrafenib (1)  ·  trametinib (1)

Sponsors

Stanford University (1)

Countries

United States (1)

Top investigators

Alexander Colevas (1)